These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 32428564)
1. Circulating inflammation-related factors are correlated with systemic redox status in IgA nephropathy; a case-control study. Apeland T; Mansoor MA; Furriol J; Ushakova A; Jonsson G; Stangeland KW; Marti HP Free Radic Biol Med; 2020 Aug; 155():10-18. PubMed ID: 32428564 [TBL] [Abstract][Full Text] [Related]
2. Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: A prospective observational study. Apeland T; Ushakova A; Mansoor MA; Furriol J; Jonsson G; Marti HP Free Radic Biol Med; 2022 Aug; 188():62-70. PubMed ID: 35716825 [TBL] [Abstract][Full Text] [Related]
3. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy. Tariq A; Mansoor MA; Marti HP; Jonsson G; Slettan A; Weeraman P; Apeland T Clin Biochem; 2018 Jun; 56():33-40. PubMed ID: 29655960 [TBL] [Abstract][Full Text] [Related]
4. TWEAK/Fn14 system and crescent formation in IgA nephropathy. Sasaki Y; Shimizu Y; Suzuki Y; Horikoshi S; Tomino Y BMC Nephrol; 2015 Mar; 16():27. PubMed ID: 25885587 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity. Li G; Wu W; Zhang X; Huang Y; Wen Y; Li X; Gao R BMC Nephrol; 2018 Nov; 19(1):326. PubMed ID: 30428849 [TBL] [Abstract][Full Text] [Related]
6. Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy. Zhu L; Guo WY; Shi SF; Liu LJ; Lv JC; Medjeral-Thomas NR; Lomax-Browne HJ; Pickering MC; Zhang H Kidney Int; 2018 Jul; 94(1):150-158. PubMed ID: 29759419 [TBL] [Abstract][Full Text] [Related]
7. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study. Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758 [TBL] [Abstract][Full Text] [Related]
8. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis. Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312 [TBL] [Abstract][Full Text] [Related]
9. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854 [TBL] [Abstract][Full Text] [Related]
10. Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study. Bi TD; Zheng JN; Zhang JX; Yang LS; Liu N; Yao L; Liu LL BMC Nephrol; 2019 Jul; 20(1):244. PubMed ID: 31272400 [TBL] [Abstract][Full Text] [Related]
11. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy. Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595 [TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy. Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Ohta K; Yachie A J Immunol Res; 2020; 2020():4284379. PubMed ID: 32537466 [TBL] [Abstract][Full Text] [Related]
13. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy. Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248 [TBL] [Abstract][Full Text] [Related]
14. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy. Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333 [TBL] [Abstract][Full Text] [Related]
15. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy. van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166 [TBL] [Abstract][Full Text] [Related]
16. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy. Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190 [TBL] [Abstract][Full Text] [Related]
17. Mapping novel immunogenic epitopes in IgA nephropathy. Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of circulating IgA isolated from patients with IgA nephropathy on superoxide and fibronectin production of mesangial cells. Chen HC; Guh JY; Chang JM; Lai YH Nephron; 2001 Jul; 88(3):211-7. PubMed ID: 11423751 [TBL] [Abstract][Full Text] [Related]
19. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study. Handa T; Kakita H; Tateishi Y; Endo T; Suzuki H; Katayama T; Tsukamoto T; Muso E Clin Exp Nephrol; 2018 Oct; 22(5):1116-1127. PubMed ID: 29564665 [TBL] [Abstract][Full Text] [Related]
20. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys. Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]